PL2918673T3 - Kompozycje do wytwarzania dojrzałych komórek dendrytycznych - Google Patents

Kompozycje do wytwarzania dojrzałych komórek dendrytycznych

Info

Publication number
PL2918673T3
PL2918673T3 PL15157220T PL15157220T PL2918673T3 PL 2918673 T3 PL2918673 T3 PL 2918673T3 PL 15157220 T PL15157220 T PL 15157220T PL 15157220 T PL15157220 T PL 15157220T PL 2918673 T3 PL2918673 T3 PL 2918673T3
Authority
PL
Poland
Prior art keywords
compositions
preparation
dendritic cells
mature dendritic
mature
Prior art date
Application number
PL15157220T
Other languages
English (en)
Inventor
Dolores J. Schendel
Iris Bigalke
Anke Zobywalski
Original Assignee
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) filed Critical Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh)
Publication of PL2918673T3 publication Critical patent/PL2918673T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2301—Interleukin-1 (IL-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
PL15157220T 2006-03-28 2007-03-28 Kompozycje do wytwarzania dojrzałych komórek dendrytycznych PL2918673T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06006373A EP1840206A1 (en) 2006-03-28 2006-03-28 Compositions for the preparation of mature dendritic cells
US82582206P 2006-09-15 2006-09-15
EP07723717.0A EP2004807B1 (en) 2006-03-28 2007-03-28 Compositions for the preparation of mature dendritic cells
PCT/EP2007/002773 WO2007110240A1 (en) 2006-03-28 2007-03-28 Compositions for the preparation of mature dendritic cells
EP15157220.3A EP2918673B1 (en) 2006-03-28 2007-03-28 Compositions for the preparation of mature dendritic cells

Publications (1)

Publication Number Publication Date
PL2918673T3 true PL2918673T3 (pl) 2019-08-30

Family

ID=36441990

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07723717T PL2004807T3 (pl) 2006-03-28 2007-03-28 Kompozycje do wytwarzania dojrzałych komórek dendrytycznych
PL15157220T PL2918673T3 (pl) 2006-03-28 2007-03-28 Kompozycje do wytwarzania dojrzałych komórek dendrytycznych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL07723717T PL2004807T3 (pl) 2006-03-28 2007-03-28 Kompozycje do wytwarzania dojrzałych komórek dendrytycznych

Country Status (13)

Country Link
US (3) US8679840B2 (pl)
EP (4) EP1840206A1 (pl)
AU (1) AU2007229640B2 (pl)
CA (1) CA2647622C (pl)
CY (1) CY1121448T1 (pl)
DK (2) DK2918673T3 (pl)
ES (2) ES2718525T3 (pl)
HU (1) HUE042138T2 (pl)
PL (2) PL2004807T3 (pl)
PT (2) PT2918673T (pl)
SI (1) SI2918673T1 (pl)
TR (1) TR201904207T4 (pl)
WO (1) WO2007110240A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1780220A1 (en) * 2005-11-01 2007-05-02 Charité - Universitätsmedizin Berlin Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis
WO2010049152A1 (en) * 2008-10-29 2010-05-06 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Novel composition for the preparation of mature dendritic cells
PL2534242T3 (pl) * 2010-02-10 2016-11-30 Polepszona kompozycja do hamowania proliferacji komórek nowotworowych
RU2575978C2 (ru) * 2010-03-15 2016-02-27 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Система и способ получения и хранения активированных зрелых дендритных клеток
EP2617434A1 (en) * 2012-01-20 2013-07-24 Laboratorios Del. Dr. Esteve, S.A. HIV-1 integrase deficient immunogens and methods for loading dendritic cells with said immunogens
JP2015513401A (ja) * 2012-03-02 2015-05-14 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ 樹状細胞ワクチンの調製方法
SI2788474T1 (sl) * 2012-12-18 2016-01-29 Immunicum Ab Ko-diferenciacija monocitov iz alogenskih darovalcev
US20150335679A1 (en) * 2014-05-20 2015-11-26 Kiromic, Llc Methods and Compositions for Treating Malignancies with Dendritic Cells
EP3317402B1 (en) 2015-06-30 2024-02-14 Universidade Nova de Lisboa A viable cell population, method for production and uses thereof
TWI752930B (zh) * 2015-12-23 2022-01-21 德商梅迪基因免疫治療公司 抗原特異性ｔｃｒ的新生成
KR101946572B1 (ko) * 2017-01-31 2019-02-11 주식회사 큐라티스 면역 관용성 플라즈마사이토이드 수지상 세포 및 그 제조방법
GB201711379D0 (en) * 2017-07-14 2017-08-30 Univ Cape Town Maturation of dendritic cells
KR102356510B1 (ko) * 2017-09-05 2022-02-08 메디진 이뮤노테라피스 게엠바하 수지상 세포 효능 분석
EP3460052B1 (en) * 2017-09-20 2019-10-30 Immunicum AB Improved allogeneic dendritic cells for use in cancer treatment
CN109182384A (zh) * 2018-09-30 2019-01-11 北京鼎成肽源生物技术有限公司 一种rff1细胞的构建方法
CN115068598A (zh) * 2022-04-25 2022-09-20 福建医科大学孟超肝胆医院(福州市传染病医院) Tlr激动剂以及包含新生抗原的免疫原性组合物在制备药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558951B1 (en) * 1999-02-11 2003-05-06 3M Innovative Properties Company Maturation of dendritic cells with immune response modifying compounds
CA2459713C (en) * 2001-09-06 2015-08-18 Northwest Biotherapeutics, Inc. Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
US20050003533A1 (en) * 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use

Also Published As

Publication number Publication date
CA2647622A1 (en) 2007-10-04
EP2918673A1 (en) 2015-09-16
HUE042138T2 (hu) 2019-06-28
US20140302096A1 (en) 2014-10-09
WO2007110240A1 (en) 2007-10-04
ES2718525T3 (es) 2019-07-02
ES2535835T3 (es) 2015-05-18
US20100284976A1 (en) 2010-11-11
US8679840B2 (en) 2014-03-25
CY1121448T1 (el) 2020-05-29
EP3517603A1 (en) 2019-07-31
EP2004807A1 (en) 2008-12-24
EP1840206A1 (en) 2007-10-03
CA2647622C (en) 2017-04-18
AU2007229640B2 (en) 2013-05-02
EP2918673B1 (en) 2019-01-16
PL2004807T3 (pl) 2015-07-31
US9512402B2 (en) 2016-12-06
DK2004807T3 (en) 2015-05-11
EP2004807B1 (en) 2015-03-04
TR201904207T4 (tr) 2019-05-21
PT2004807E (pt) 2015-05-20
AU2007229640A1 (en) 2007-10-04
DK2918673T3 (en) 2019-04-01
SI2918673T1 (sl) 2019-05-31
PT2918673T (pt) 2019-04-23
US20170037372A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
SI2918673T1 (sl) Sestavki za pripravo zrelih dendritičnih celic
AP2008004713A0 (en) Improvements relating to anti-parasetic compositions
GB2453249B (en) Fuel compositions
GB2453248B (en) Fuel compositions
GB0623838D0 (en) Novel compositions
ZA201103926B (en) Stable sulfoximine-insecticide compositions
EP2225351A4 (en) RENEWABLE COMPOSITIONS
MX283608B (en) Fuel compositions comprising tetramethylcyclohexane
EP2197449A4 (en) NOVEL OPHTHALMIC COMPOSITIONS
IL199941A0 (en) Compositions of stable tiacumicins
PL2278958T3 (pl) Kompozycje do doustnego dostarczania kortykosteroidów
ZA201001913B (en) Fuel compositions
GB0607085D0 (en) Novel compositions
GB0713707D0 (en) Stable compositions
GB0724498D0 (en) Slow release compositions
ZA201002504B (en) Novel taxoid-based compositions
ZA201102764B (en) Composition for targeting dendritic cells
EP2178539A4 (en) PHOSPHOLIPIDE COMPREHENSIVE COMPOSITIONS
GB0718380D0 (en) Novel method & compositions
GB0917779D0 (en) Novel compositions
HK1171733A (en) Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid
HK1133196A (en) Stable imatinib compositions
AU2007906641A0 (en) Novel Compositions
AU2007900487A0 (en) Slow release water delivery composition
HK1147680A (en) Avenanthramide-containing compositions